Increase in brain connectivity with methylphenidate treatment in boys diagnosed with attention deficit hyperactivity disorder: A coherence-based qeeg analysis

Increase in brain connectivity with methylphenidate treatment in boys diagnosed with attention deficit hyperactivity disorder: A coherence-based qeeg analysis

Introduction Attention deficit hyperactivity (ADHD) disorder is a common childhood neurodevelopmental disorder, and Methylphenidate (MPH) is a first-line therapeutic option for treating ADHD.However, how brain connectivity changes with methylphenidate treatment have yet to be studied. Objectives...

Descrizione completa

Dettagli Bibliografici
Autori principali:	F.H. Çetin, Ş. Gıca, M. Çıkılı Uytun, Z. Babadağı, M.B. Usta, A.S. Güven, Y. Işık
Natura:	Articolo
Lingua:	English
Pubblicazione:	Cambridge University Press 2021-04-01
Serie:	European Psychiatry
Soggetti:	ADHD methylphenidate qEEG connectivity
Accesso online:	https://www.cambridge.org/core/product/identifier/S0924933821016862/type/journal_article

Documenti analoghi

Decrease in brain complexity with methylphenidate treatment in boys diagnosed with attention deficit hyperactivity disorder: An entropy-based qeeg analysis
di: F.H. Çetin, et al.
Pubblicazione: (2021-04-01)

Parent-reported social problems and clinician-evaluated adverse effects may be differentially affected by differing extended release methylphenidate formulations: a prospective, naturalistic study from Turkey
di: Merve Cikili Uytun, et al.
Pubblicazione: (2019-10-01)

Quantitative electroencephalography – A promising biomarker in children with attention deficit/hyperactivity disorder
di: Mini Sharma, et al.
Pubblicazione: (2022-01-01)

Are psychiatric comorbidities and associated cognitive functions related to treatment response to methylphenidate in boys with attention-deficit/hyperactivity disorder?
di: Chan MH, et al.
Pubblicazione: (2017-04-01)

Attention Deficit Hyperactivity Disorder and Methylphenidate: When Society Misunderstands Medicine
di: David D. Kaminester
Pubblicazione: (2020-12-01)

Effects of methylphenidate on height, weight and blood biochemistry parameters in prepubertal boys with attention deficit hyperactivity disorder: an open label prospective study
di: Çevikaslan Ahmet, et al.
Pubblicazione: (2021-01-01)

Decreased Risk of Influenza in Child and Adolescent Patients with Attention-Deficit Hyperactivity Disorder Following Methylphenidate Treatment: A Nationwide Cohort Study in Taiwan
di: Lee H, et al.
Pubblicazione: (2020-05-01)

Effect of one-month treatment with methylphenidate on salivary cortisol level of attention deficit hyperactivity disorder children
di: Esraa Yahia Kholif, et al.
Pubblicazione: (2021-03-01)

Neural Markers of Methylphenidate Response in Children With Attention Deficit Hyperactivity Disorder
di: Anne B. Arnett, et al.
Pubblicazione: (2022-05-01)

Effect of methylphenidate on substance use disorders in children and adolescents with attention-deficit/hyperactivity disorder: a systematic review
di: Andreia Coutinho, et al.
Pubblicazione: (2024-10-01)

ADHD, Methylphenidate, and Childhood Epilepsy
di: Rahul Sharma, et al.
Pubblicazione: (2016-08-01)

Methylphenidate-Induced Raynaud’s Phenomenon In Two Cases With Attention-Deficit/Hyperactivity Disorder
di: Ömer Faruk Akça, et al.
Pubblicazione: (2021-05-01)

Does Methylphenidate Work in Children and Adolescents with Attention Deficit Hyperactivity Disorder?
di: Johanne Pereira Ribeiro, et al.
Pubblicazione: (2021-08-01)

Modified-release methylphenidate-induced Raynaud’s phenomenon in an adolescent with attention deficit hyperactivity disorder
di: Ali Karayağmurlu, et al.
Pubblicazione: (2022-09-01)

Long-term neurocognitive effects of methylphenidate in patients with attention deficit hyperactivity disorder, even at drug-free status
di: Huang Yu-Shu, et al.
Pubblicazione: (2012-11-01)

Alopecia associated with use of methylphenidate: A case series
di: Sundar Gnanavel, et al.
Pubblicazione: (2018-01-01)

Diagnosing ADHD using QEEG and planning EEG-biofeedback (Neurofeedback) therapy – pilot studies
di: Danuta Bogumiła Ochojska, et al.
Pubblicazione: (2021-02-01)

Methylphenidate for Attention-Deficit and Hyperactivity Disorder in Adult Patients With Substance Use Disorders: Good Clinical Practice
di: Sunsha Chamakalayil, et al.
Pubblicazione: (2021-01-01)

Methylphenidate in ADDH and Epilepsy
di: J Gordon Millichap
Pubblicazione: (1994-10-01)

A comparison of effectiveness of regulation of working memory function and methylphenidate on remediation of attention deficit hyperactivity disorder (ADHD).
di: Mohammad Reza Mohammadi, et al.
Pubblicazione: (2014-03-01)

Case report: Methylphenidate improved chronic pain in an adult patient with attention deficit hyperactivity disorder
di: Ekachaeryanti Zain, et al.
Pubblicazione: (2023-03-01)

Editorial: Attention and Methylphenidate
di: Avi Avital, et al.
Pubblicazione: (2020-04-01)

Quality of life in a sample of schoolchildren with attention deficit and hyperactivity disorder
di: S. Pérez Sánchez, et al.
Pubblicazione: (2021-04-01)

NIRS Hemodynamic Response to Methylphenidate in Children with Attention Aeficit Hyperactivity Disorder: First Administration, Titration Phase and Associations with Clinical Severity
di: A. Crippa, et al.
Pubblicazione: (2022-06-01)

Review and Meta-analysis on the Impact of the ADRA2A Variant rs1800544 on Methylphenidate Outcomes in Attention-Deficit/Hyperactivity Disorder
di: Daniel T. Hain, et al.
Pubblicazione: (2022-04-01)

Attention-deficit/hyperactivity disorder
di: A. M.E. du Plessis
Pubblicazione: (2015-05-01)

Análise da eficácia do metilfenidato usando a versão abreviada do questionário de conners em transtorno de déficit de atenção/hiperatividade Analysis of the methylphenidate's efficacy using the abbreviated version Conners' questionnaire in attention deficit hyperactivity disorder
di: Ênio Roberto de Andrade, et al.
Pubblicazione: (2004-03-01)

A randomised controlled trial of combined EEG feedback and methylphenidate therapy for the treatment of ADHD
di: Li Li, et al.
Pubblicazione: (2013-08-01)

Practical clinical guidelines and pharmacological treatment for attention‐deficit hyperactivity disorder in Asia
di: Kentaro Kawabe, et al.
Pubblicazione: (2024-03-01)

The age-dependent effects of a single-dose methylphenidate challenge on cerebral perfusion in patients with attention-deficit/hyperactivity disorder
di: A Schrantee, et al.
Pubblicazione: (2017-01-01)

Evaluation of two types of drug treatment with QEEG in children with ADHD
di: Aldemir Ramazan, et al.
Pubblicazione: (2018-09-01)

Synaptosomal-Associated Protein 25 Gene Polymorphisms Affect Treatment Efficiency of Methylphenidate in Children With Attention-Deficit Hyperactivity Disorder: An fNIRS Study
di: Jie Li, et al.
Pubblicazione: (2022-01-01)

Attention deficit hyperactivity disorder - symptoms, diagnosis and therapy among children and adults.
di: Agata Surowiec, et al.
Pubblicazione: (2023-08-01)

Evaluating the relationship between Ex3 vNTR and rs3758653 polymorphisms in DRD4 genes in children with attention deficit hyperactivity disorder with respect to the dose of methylphenidate
di: Shahrokh Amiri, et al.
Pubblicazione: (2022-12-01)

Methylphenidate does not affect convergent and divergent creative processes in healthy adults
di: Matthijs Baas, et al.
Pubblicazione: (2020-01-01)

Prescribing patterns for attention deficit hyperactivity disorder among children and adolescents in Taiwan from 2004 to 2017
di: Heng-Ching Liao, et al.
Pubblicazione: (2023-06-01)

Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis
di: Jain Rakesh, et al.
Pubblicazione: (2011-11-01)

Memantine versus Methylphenidate in Children and Adolescents with Attention Deficit Hyperactivity Disorder: A Double-Blind, Randomized Clinical Trial
di: MohammadReza Mohammadi, et al.
Pubblicazione: (2016-02-01)

Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II)
di: Philip Asherson, et al.
Pubblicazione: (2019-12-01)

Tolerance to Stimulant Medication for Attention Deficit Hyperactivity Disorder: Literature Review and Case Report
di: Kenneth Handelman, et al.
Pubblicazione: (2022-07-01)